Jazz Seeks Potential Expansion Of Epilepsy Franchise With Saniona Deal

Upfront Fee Seen As Reasonable Investment

 
• By Mandy Jackson
  
SAN2355 will be developed for epilepsy and other neurological disorders (Shutterstock)

More from Deals

More from Business